Overview

Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The objective of the trial is to investigate efficacy and safety of ingenol mebutate gel for actinic keratosis applied to large treatment areas once daily for three consecutive days on face, scalp or chest.
Phase:
Phase 3
Details
Lead Sponsor:
LEO Pharma